*Result*: Antiangiogenic properties of axitinib versus sorafenib following sunitinib resistance in human endothelial cells — a view towards second line renal cell carcinoma treatment

*Published in*:
Biomedicines. - Basel : MDPI, 06.11.2021. - Seite 1-14. - 10.3390/biomedicines9111630. - ISSN 2227-9059. - Jahrgang 9, Heft 11, Artikel 1630
*Publication*:
Basel : MDPI, 06.11.2021
*Distribution*:
Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg
*Physical description scale*:
1 Online-Ressource (14 Seiten)
*Format*:
*eBook*
*Language*:
*eng*
*DOI*:
10.3390/biomedicines9111630
*oa_rights*:
Open Access
CC BY 4.0